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Clinical presentation, diagnostic findings and
long-term survival in large breed dogs with
meningoencephalitis of unknown aetiology
I. Cornelis, H. A. Volk, S. De Decker
Although several studies indicate that meningoencephalitis of unknown aetiology (MUA)
might affect every dog breed at every age, little is known about clinical presentation,
diagnostic findings and long-term survival in large breed dogs. The aim of this study was
therefore to compare the clinical presentation, diagnostic findings and long-term survival
between large and small/medium breed dogs diagnosed with MUA. One hundred and eleven
dogs met the inclusion criteria. 28 (25 per cent) dogs were considered large breed dogs
compared with 83 (75 per cent) small/medium breed dogs. Large breed dogs presented
significantly more often with a decreased mentation. Age, gender, duration of clinical signs
prior to diagnosis, presence of seizures or cluster seizures, variables on complete blood count
and cerebrospinal fluid analysis, and all variables on MRI were not significantly different
between small/medium and large breed dogs. Median survival time was 281 and 106 days
for the large and small/medium breed dogs, respectively, with no significant difference in
survival curves for both groups. Although considered not typically affected by MUA, 25 per
cent of dogs included in this study were considered large breed dogs. Therefore, MUA should
be included in the differential diagnosis for large breed dogs presenting with intracranial
neurological signs. If diagnosed with MUA, large breed dogs also carried a guarded
prognosis.
Meningoencephalitis of unknown aetiology (MUA) is a group
of idiopathic non-infectious central nervous system (CNS) dis-
eases, with a likely multifactorial pathogenesis (Talarico and
Schatzberg 2010). The term MUA has been introduced to
encompass all clinically diagnosed cases of non-infectious
inflammatory diseases of the CNS with lacking of histopatho-
logical confirmation. More specifically, this group includes
encephalopathies such as granulomatous meningoencephalitis
(GME), necrotising meningoencephalitis (NME) and necrotising
leucoencephalitis (NLE) (Zarfoss and others 2006, Talarico and
Schatzberg 2010). Middle-aged female toy and terrier breeds are
considered predisposed to develop GME (Munana and Luttgen
1998, Adamo and others 2007, Talarico and Schatzberg 2010).
Necrotising encephalitis (including NME and NLE) predomin-
antly affects toy and small breed dogs including Yorkshire terrier,
Maltese terrier, French bulldog, shih tzu, Lhasa apso,
Chihuahua, pug, Pekingese, papillon, Coton de Tulear and
Brussels griffon (Talarico and Schatzberg 2010, Cooper and
others 2014). Although it is stated that dogs of any breed and
age can be affected by MUA (Coates and Jeffery, 2014), literature
regarding differences in clinical presentation, diagnostic findings
and long-term survival between small/medium and large breed
dogs is currently unavailable. It is unknown whether the non-
infectious inflammatory encephalopathies diagnosed in large
breed dogs are just a variation on a common aetiological theme
or represent a truly different aetiology compared with the
various almost breed-specific encephalitides regularly diagnosed
in small/medium breed dogs. The aims of this study were there-
fore to describe the clinical presentation, diagnostic findings and
long-term survival in large breed dogs diagnosed with MUA
compared with small/medium breed dogs. The authors hypothe-
sised that no differences would be detected in clinical presenta-
tion, diagnostic findings and long-term survival between small/
medium and large breed dogs diagnosed with MUA.
Materials and methods
Case selection
The electronic medical database of the Small Animal Referral
Hospital, Royal Veterinary College, University of London, was
searched between January 2006 and April 2015 for dogs diag-
nosed with ‘MUO’, ‘MUA’, ‘GME’, ‘NME’, ‘NLE’, ‘inflammatory
CNS disease’, ‘non-infectious meningoencephalitis’ and the fully
written versions of the above-mentioned abbreviations. Dogs
were included based on the criteria used by Granger and others
(2010) if they had (1) complete medical records available; (2) a
complete neurological examination performed leading to a focal
or multifocal intracranial neuroanatomical localisation; (3)
inflammatory cerebrospinal fluid (CSF) analysis; (4) MRI of the
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brain demonstrating single, multiple or diffuse intra-axial hyper-
intense lesions on T2W images; and (5) outcome data available
through revision of medical records or contacting the referring
veterinarian by email or telephone. Dogs were excluded if (1) the
clinical records or imaging studies were incomplete or not avail-
able for review; (2) dogs were diagnosed with meningomyelitis
without clinical signs of intracranial involvement; (3) no pleocy-
tosis was found on CSF analysis with the exception of dogs
with signs of raised intracranial pressure on imaging studies, in
which case CSF collection was not performed; and if (4)
outcome data were unavailable. Dogs with histopathological
confirmation of the disease only needed to fulfil inclusion criteria
(1) and (5).
Dogs weighing >15 kg were considered large breed dogs,
dogs <15 kg were considered small/medium breed dogs. For dog
breeds were the body weight varied around 15 kg, mean body
weight for male and female dogs as reported on the Kennel Club
website (http://www.thekennelclub.org.uk/services/public/
breed/standard-find.aspx) was used to consider them large or
medium/small breed dogs. Information retrieved from the
medical records included breed, age at diagnosis, gender, body
weight, results of general physical and neurological examination
and neuroanatomical localisation, duration of clinical signs
before diagnosis, results of complete blood count (CBC) and bio-
chemistry profile, results of CSF analysis and lactate concentra-
tion on venous blood gas analysis. Duration of clinical signs
before diagnosis was classified as peracute (less than two days),
acute (two to seven days) or chronic (more than seven days). For
dogs that had CSF analysis performed, site of collection (cister-
nal or lumbar), total nucleated cell count (TNCC), total protein
(TP) concentration and nucleated cell differential count were
recorded. TNCC was considered normal if the TNCC <5 cells/
mm3. Protein concentration was considered normal for a cister-
nal collection if <0.25 g/l and for a lumbar collection if <0.4 g/l.
Possible neuroanatomical localisations included forebrain, brain-
stem or cerebellum. Dogs with vestibular signs attributable to an
intracranial lesion were diagnosed with central vestibular signs.
If more than two of the above-mentioned regions appeared to be
affected on the neurological examination, dogs were given a
multifocal neuroanatomical localisation, where dogs with only
one region affected were given a focal neuroanatomical localisa-
tion. MRI was performed under general anaesthesia with a per-
manent 1.5 T magnet (Intera, Philips Medical Systems,
Eindhoven, the Netherlands) and all images were reviewed by a
board-certified neurologist (SDD) using Osirix DICOM viewer
(Osirix Foundation, V.5.5.2 Geneva, Switzerland). The reviewer
was blinded for signalment, results of the neurological examin-
ation and postmortem examination findings if available.
Sequences could vary, but studies included a minimum of
T2-weighted (T2W) (repetition time (ms) (TR)/echo time (ms)
(TE), 3000/120), T1-weighted (T1W) (TR/TE, 400/8) and fluid
attenuating inversion recovery (FLAIR) images of the entire
brain in a sagittal, transverse and dorsal plane. The T1W images
were acquired before and after intravenous administration of
paramagnetic contrast medium (0.1 mg/kg, gadoterate meglu-
mine, Dotarem, Guerbet, Milton Keynes, UK). Variables recorded
were lesion localisation and distribution, presence of parenchy-
mal or meningeal contrast enhancement and presence of mass
effect (brain herniation, midline shift, flattening of gyri/sulci).
Statistical analysis
Data analysis was performed with the aid of a standard statis-
tical software package (Prism, GraphPad Software, La Jolla,
California, USA). A Mann-Whitney U test was used to compare
age, duration of clinical signs before diagnosis, venous blood
lactate levels, white blood cell (total, neutrophil and lympho-
cyte) count on CBC, TNCC and TP concentration in CSF
between small/medium and large breed dogs. A Fisher ’s exact
test was used to compare differences in gender, presence of sei-
zures and cluster seizures, neuroanatomical localisation (menta-
tion, forebrain, brainstem, central vestibular) and imaging
findings (lesion localisation, meningeal or parenchymal contrast
enhancement, mass effect, brain herniation, flattening gyri/sulci,
rostral or caudal transtentorial herniation, foramen magnum her-
niation) between small/medium and large breed dogs. Numeric
variables were expressed as median and interquartile range. A
false discovery rate (FDR) as used by Benjamini and others
(2001) was applied to control for the increased risk of falsely sig-
nificant results in the multiple comparisons. Values of P<0.05
were considered significant. Survival analysis was performed
using both a log-rank (Mantel-Cox) and Gehan-Breslow-
Wilcoxon test, resulting in median survival time (MST) calcula-
tion and Kaplan-Meier survival curves comparing survival per-
centage in small/medium and large breed dogs. Survival was
defined as time from diagnosis to death or euthanasia, including
whether this happened because of disease progression or due to
unrelated causes, or time from diagnosis to data collection for
dogs that were alive at the time of data capture. Dogs that died
because of unrelated causes and dogs that were still alive at the
time of data capture were censored for calculations.
Results
Signalment
Database research revealed 549 results. Dogs were excluded if
they did not match the inclusion criteria or if they strictly met
the inclusion criteria, but the combination of clinical presenta-
tion and imaging findings was more suggestive for another intra-
cranial disorder (neoplasia, vascular lesion) was considered more
likely. Finally, 111 dogs were included in this study. These
included 28 (25 per cent) large breed and 83 (75 per cent) small/
medium breed dogs. Large breed dogs included English springer
spaniel (n=6), cross-breed (n=5), labrador retriever (n=4),
golden retriever (n=2), Akita (n=2), and one each of the follow-
ing breeds: Border collie, boxer, Bernese mountain dog, curly-
coated retriever, German wire-haired pointer, Great Dane,
Shar-Pei, Siberian husky and Welsh springer spaniel. Compared
with the general hospital population admitted between January
2006 and April 2015, English springer spaniels were not signifi-
cantly over-represented (P=0.196). Small breeds included West
Highland white terrier (n=22), Chihuahua (n=8), Maltese
terrier (n=8), pug (n=8), French bulldog (n=7), Cavalier King
Charles spaniel (n=6), cross-breed (n=6), Yorkshire terrier
(n=5), Border terrier (n=2), Boston terrier (n=2), Pomeranian
(n=2), poodle (n=2) and one each of the following breeds:
Bichon Frise, Welsh Corgi Cardigan, Lhasa apso, papillon and
Sheltie.
Clinical presentation and diagnostic findings
Large breed dogs had a significant shorter duration of clinical
signs before diagnosis (P=0.012), more often presented with
decreased mentation (<0.0001) and less often with cranial nerve
deficits (P=0.027), and were more often diagnosed with a brain-
stem lesion on MRI (P=0.039) compared with small/medium
breed dogs. However, when an FDR of 10 per cent was applied,
only decreased mentation was found to be significantly different
between both groups (Table 1). Gender, age at presentation,
neuroanatomical localisation, presence of seizures and cluster sei-
zures, lactate concentration on venous blood gas analysis, TNCC
and TP concentration on CSF analysis and the remaining MRI
findings (meningeal or parenchymal contrast enhancement,
mass effect, brain herniation, flattening gyri/sulci, rostral or
caudal transtentorial herniation, foramen magnum herniation)
were not different between small/medium and large breed dogs.
All statistical results can be consulted in Table 1, and a clinical
summery regarding the large breed dogs can be consulted in
Table 2.
Serological testing and/or PCR for Canine Distemper virus,
Toxoplasma gondii and Neospora caninum was performed in 19 (68
per cent) large breed dogs and in 59 (71 per cent) small/medium
breed dogs. Of the nine large breed dogs that did not undergo
infectious disease testing, one dog had complete postmortem
examination performed and four dogs were still alive at the time
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of data capture with survival times ranging from 184 to
2039 days. These four dogs were all treated with an immunosup-
pressive treatment protocol. The four remaining large breed dogs
died within 20 days after diagnosis and breeds included English
springer spaniel, cross-breed, Siberian husky and Akita.
Postmortem examination was performed in 14 dogs, 8 small/
medium breed and 6 large breed dogs. Results included GME
(five small/medium breed, four large breed), NME (three small
breed, one large breed) and NLE (one large breed dog).
Outcome
All 111 dogs were initiated on immunosuppressive doses of glu-
cocorticosteroids at the time of diagnosis, combined with cyto-
sine arabinoside in 66 (80 per cent) small/medium breed dogs
and 18 (64 per cent) large breed dogs. Most dogs on cytosine ara-
binoside therapy had regular (three to four weekly)
re-examinations at a dedicated cytosine arabinoside clinic.
Overall, dogs that were alive at the time of data capture were
dogs that received sole prednisolone therapy or combined pred-
nisolone and cytosine arabinoside treatment.
At the time of data capture, 11 (39 per cent) large breed dogs
and 27 (33 per cent) small/medium breed dogs were alive.
Conversely, 17 (61 per cent) large breed and 56 (67 per cent)
small/medium breed dogs had died. Of the deceased dogs, 15 (88
per cent) large breed dogs and 47 (84 per cent) small/medium
breed dogs died or were euthanased because of disease progres-
sion compared with 2 (12 per cent) large breed dogs and 9 (16
per cent) small/medium breed dogs that died or were euthanased
for unrelated causes. Overall, 54 per cent of the large breed dogs
and 57 per cent of the small/medium breed dogs died or were
euthanased because of disease progression. The MST was 281
and 106 days for the small/medium and large breed dogs,
respectively. There was no significant difference in survival
curves between small/medium and large breed dogs (P=0.664)
(Fig 1).
Discussion
This study evaluated the differences in clinical presentation,
diagnostic findings and long-term survival between small/
medium and large breed dogs diagnosed with MUA. Large breed
dogs were found to present significantly more often with a
decreased mentation. No significant difference was seen in sur-
vival curves between small/medium and large breed dogs. To the
best of the authors’ knowledge, this is the first study describing
clinical, diagnostic and outcome data in large breed dogs with
MUA. MUA is generally considered a syndrome affecting small,
toy and terrier breed dogs aged between approximately three and
seven years (Munana and Luttgen 1998, Adamo and others 2007,
Talarico and Schatzberg 2010, Coates and Jefferey 2014).
However, a total of 47 large breed dogs are present in the litera-
ture from 1998 to 2015. The distribution of the breeds in this
study appears to be similar. Although the English springer
spaniel was the most common large dog breed in this study, it
was not significantly over-represented compared with the
general hospital population. The higher number of this breed in
this study therefore likely reflects its popularity in the UK. MUA
occurred, as expected, more often in small/medium breed dogs,
but still a quarter of dogs in the presented study were large breed
dogs. Ignoring this population of dogs would underestimate the
prevalence of MUA in the overall canine population. Therefore,
MUA should be considered as a differential diagnosis in dogs
other than small or toy breeds that have signs suggestive of
inflammatory brain disease.
Large breed dogs were more likely to present with a decreased
mentation compared with their small/medium breed counter-
parts. Abnormal mentation in dogs can be caused by lesions in
the forebrain (telencephalon and diencephalon) and/or brainstem
(mesencephalon, metencephalon, myelencephalon) (Garosi
2013). A lesion in the brainstem is considered a typical MRI
finding in cases of GME and NLE, but is considered an uncom-
mon finding in dogs with NME (Coates and Jefferey 2014).
However, histopathological lesions have been identified in the
brainstem of Chihuahua and pug dogs with NME (Higgins and
others 2008, Park and others 2012). In the presented study, both
small/medium and large breed dogs were histopathologically
diagnosed with GME and NME, and one large breed dog was
diagnosed with NLE, which has not yet been previously
described. In literature, NLE is mainly affecting Yorkshire terriers,
Maltese terriers and a French bulldog (Schatzberg 2005,
Higginbotham and others 2007, Timmann and others 2007,
Spitzbarth and others 2010), which are all considered small/
medium breed dogs in this study. NME has only been once previ-
ously described in a large breed dog; a 26 kg Staffordshire bull
terrier mix (Estey and others 2014).
A limitation of the current study is the lack of histopatho-
logical confirmation in the majority of cases, which makes inclu-
sion of other diseases than MUA possible (mainly
cerebrovascular or neoplastic disease). Based on intracranial MRI,
seven imaging abnormalities have been associated with neoplas-
tic brain disease in one study (Cherubini and others 2005). These
included the presence of a single lesion, regular lesion shape,
presence of mass effect, dural contact, dural tail sign, lesions
affecting adjacent bone and contrast enhancement (Cherubini
and others 2005). Another study demonstrated MRI to be 94.4
per cent sensitive and 95.5 per cent specific for detection of a
brain lesion and for classifying neoplastic and inflammatory
TABLE 1: Investigated variables in small/medium and large
breed dogs diagnosed with meningoencephalitis of unknown
aetiology
Variable
Small/medium
breed dogs
(n=83)
Large breed
dogs (n=28) P value/FDR
Signalment
Age (months) 52 (6–146) 60 (10–120) 0.7373/0.0678
Male 44 (53%) 17 (61%) 0.0653/0.0143
Female 39 (47%) 11 (39%) 0.0653/0.0178
Duration of clinical signs
before diagnosis (days)
8 (1–180) 5 (1–60) 0.0116/0.0071
Clinical signs
Seizures 19 (23%) 10 (36%) 0.2164/0.0286
Cluster seizures 13 (16%) 7 (25%) 1.0000/0.0929
Neuroanatomical localisation
Forebrain 58 (70%) 22 (79%) 0.4875/0.0464
Brainstem 53 (64%) 18 (64%) 1.0000/0.0964
Central vestibular 27 (33%) 4 (14%) 0.0904/0.0214
Abnormal mentation 26 (31%) 25 (89%) <0.0001/0.0036*
Bloodwork
WBCs (0.109/l) 10.6 (3.52–32.8) 9.8 (4.66–25.1) 0.5888/0.05
Neutrophils (0.109/l) 7.5 (2.4–28.3) 7.1 (3.2–22.3) 0.4420/0.0429
Lymphocytes (0.109/l) 1.3 (0.1–3.6) 1.2 (0.3–2.7) 0.3434/0.0393
Venous blood gas
Lactate (mmol/l) 1.5 (0.6–3.6) 1.6 (0.4–10.4) 0.8711/0.0786
CSF analysis
TNCC (WBC/mm3) 97 (1–2560) 48 (1–2220) 0.3360/0.03572
Total protein (g/l) 0.54 (0.11–3.51) 0.43 (0.1–8.47) 0.7872/0.0714
MRI findings
Focal lesion 24 (29%) 7 (25%) 0.7163/0.0607
Multifocal lesion 57 (69%) 20 (71%) 0.7335/0.0643
Diffuse lesion 6 (7%) 2 (7%) 1.0000/0.1
Forebrain localisation 66 (80%) 23 (82%) 0.7035/0.0571
Brainstem localisation 41 (49%) 20 (71%) 0.0414/0.0107
Cerebellar localisation 16 (19%) 5 (18%) 0.8893/0.0821
Mass effect 53 (64%) 13 (46%) 0.1297/0.025
Brain herniation 34 (41%) 10 (36%) 0.6586/0.0536
Caudal transtentorial
herniation
29 (35%) 10 (36%) 0.9097/0.0857
Foramen magnum
herniation
23 (28%) 7 (25%) 0.8066/0.075
Midline shift 31 (37%) 7 (25%) 0.2534/0.321
Flattening gyri/sulci 38 (46%) 13 (46%) 0.9140/0.0893
Values are numbers with their percentage, or a median with interquartile range
between parentheses
*P value below the FDR threshold and thus considered to be significant
FDR, false discovery rate; TNCC, total nucleated cell count; WBC, white blood cells
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disease correctly, but was only 38.9 per cent sensitive for classify-
ing cerebrovascular disease (Wolff and others 2012). For the pre-
sented study, six large breed dogs had a focal lesion on MRI of
the brain, where inflammatory lesions are more typically asso-
ciated with multifocal or diffuse lesions on intracranial imaging
(Cherubini and others 2006). Two of those lesions were histo-
pathologically confirmed as GME or NME. Of the four remain-
ing dogs, one dog (Siberian husky) had a focal lesion in the
frontal lobe that showed presence of mass effect, parenchymal
contrast enhancement and dural contact. Although abnormal-
ities on CSF analysis do not exclude neoplastic or vascular
disease (REF), this dog had an increased TNCC (35 WBC/mm3)
and TP concentration (0.35 g/l) on cisternal CSF analysis. The
dog was only 30 months old and died acutely at home 18 days
after diagnosis after initial improvement on immunosuppressive
therapy. The second, third and fourth dogs (two cross-breeds
and an English springer spaniel) were 26–85 months old at the
time of diagnosis and had a focal lesion in the piriform lobe
(cross-breed) or brainstem (cross-breed and an English springer
spaniel). All three dogs had increased TNCC and TP concen-
trations on cisternal CSF analysis, and all were alive 1095–
1580 days after diagnosis. All dogs had an acute onset of
neurological signs, which might still be compatible with cere-
brovascular disease, that might be supported by the long
survival without treatment of those dogs. However, in
TABLE 2: Overview of breed, age, duration of clinical signs before diagnosis, infectious disease testing results, TNCC in CSF, TP
concentration in CSF, MRI findings, ST and postmortem (PM) examination findings for the large breed dogs included in this study
Breed
Age at
presentation
(months)
Duration clinical signs
before presentation
(#days)
Serology or PCR on
CSF performed
TNCC
(WBC/
mm3)
TP
(g/l)
MRI findings (lesion
localisation)
ST
(days)
PM
diagnosis
Akita 36 2 Yes 2220 4.65 Multifocal lesions brainstem
and spinal cord
2 NP
Bernese mountain
dog
45 21 Yes 12 0.38 Multifocal lesions forebrain
and brainstem
120 NP
Border collie 70 7 Yes 300 2.47 Multifocal lesions forebrain
and cerebellum
92 Alive
Boxer 68 60 No NP NP Multifocal lesions forebrain,
brainstem and cerebellum
1 GME
Cross-breed 85 5 No 23 0.26 Focal lesion forebrain 1580 Alive
64 30 No 1255 1.31 Multifocal lesions forebrain,
brainstem and spinal cord
5 NP
23 3 Yes 555 1.92 Focal lesion brainstem 1 GME
26 4 Yes 1090 8.47 Focal lesion brainstem 1095 Alive
12 5 Yes 90 0.62 Multifocal lesions forebrain,
brainstem and cerebellum
2708 Alive
Curly-coated
retriever
63 38 Yes 80 0.78 Multifocal lesions forebrain,
brainstem and cerebellum
2190 Alive
English springer
spaniel
61 5 Yes 62 0.6 Multifocal lesions forebrain
and brainstem
2950 Alive
60 2 No 17 0.75 Diffuse lesions forebrain 1 NP
47 1 Yes 12 0.16 Multifocal lesions brainstem 72 Alive
61 5 No 29 0.23 Multifocal lesions forebrain
and brainstem
2039 Alive
39 1 Yes 173 0.68 Focal lesion brainstem 1187 Alive
78 2 Yes NP NP Multifocal lesions forebrain,
brainstem and cerebellum
700 Alive
German
wire-haired
pointer
10 4 Yes 12 0.23 Multifocal lesions forebrain
and brainstem
975 Alive
Golden retriever 75 7 Yes 1 0.21 Multifocal lesions forebrain
and brainstem
1 GME
60 7 Yes 22 0.46 Multifocal lesions forebrain
and brainstem
1856 Alive
Great Dane 60 2 Yes 40 0.1 Multifocal lesions forebrain 1 NP
Japanese Akita 20 2 No 51 0.41 Multifocal lesions forebrain
and brainstem
1 NP
Labrador 120 13 Yes 8 0.1 Focal lesion forebrain 3 NME
47 7 Yes 3 0.24 Multifocal lesions forebrain
and brainstem
1 NLE
27 7 No NP NP Diffuse lesions forebrain 184 Alive
94 3 No 30 0.43 Multifocal lesions forebrain
and brainstem
730 Alive
Shar-Pei 36 9 Yes NP NP Multifocal lesions forebrain 2129 Alive
Siberian husky 30 2 No 68 0.35 Focal lesion forebrain 18 NP
Welsh springer
spaniel
89 21 Yes 675 5.56 Multifocal lesions forebrain
and brainstem
3 GME
GME, granulomatous meningoencephalitis; NLE, necrotising leucoencephalitis; NME, necrotising meningoencephalitis; NP, not performed; ST, survival time; TP, total protein;
TNCC, total nucleated cell count; WBC, white blood cells
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FIG 1: Kaplan-Meier survival curve comparing the percentage of
survival in small/medium (full black line) and large (dotted line)
breed dogs. Results were censored for dogs that were still alive at
the time of data capture (single little blocks)
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cerebrovascular disease, contrast enhancement should only be
visible after 7–10 days in dogs with ischaemic infarcts, and
after 6 days to 6 weeks in dogs with haemorrhagic infarcts
(Garosi 2012). All dogs with a focal lesion had intracranial
imaging within five days after onset of neurological signs, and
all lesions showed parenchymal contrast enhancement, which
was considered less typical for cerebrovascular disease.
Neoplastic disease can however not be excluded in those cases,
although all four dogs were still young at the time of diagnosis
(two to five years of age) where brain tumours are typically
affecting middle-aged to older (over five years) dogs and cats,
with the majority being greater than nine years of age (Snyder
and others 2006, Dickinson 2014).
Infectious disease testing was lacking in approximately 30 per
cent of both small/medium and large breed dogs. The nine large
breed dogs that were not tested had focal (n=2), multifocal
(n=5) or diffuse forebrain (n=2) lesions on MRI. Necrotising cer-
ebellitis and cerebellar atrophy (Garosi and others 2010) as well as
multifocal brain involvement (Parzefall and others 2014) have
been described in association with N. caninum infection in dogs.
In the study of Parzefall and others (2014), mild cerebellar
atrophy was additionally seen in three of four dogs. In the pre-
sented study, 11 large breed dogs died within 20 days after diag-
nosis and after immunosuppressive treatment. Postmortem
examination confirming GME, NLE or NME was performed in 6/
11 dogs. Of the five remaining dogs, all but one (Siberian husky)
had multifocal or diffuse forebrain lesions without cerebellar
involvement, and showed no signs of perilesional oedema on
FLAIR images as described by Parzefall and others (2014). MRI
features of T. gondii encephalitis have not yet been described for
dogs, but it is known to cause focal granuloma formation both in
the forebrain (Pfohl and others 2005, Falzone and others 2008)
and the spinal cord (Alves and others 2011) of cats. The four dogs
with multifocal or diffuse brain lesions all had an increased
TNCC with a mononuclear pleocytosis but without signs of
presence of lymphoblastic cells. No further diagnostic investiga-
tions for lymphoma were performed. Gliomatosis cerebri is a
CNS neoplasia that is mainly affecting brachycephalic breeds
(boxer, Boston terrier, English bulldog, bull mastiff ) and MRI
mainly reveals single lesions in thalamus and/or brainstem,
although the cerebrum can be involved and sometimes no lesions
are visible (Bentley and others 2014). This differential diagnosis
seems less likely in these four dogs because of their breeds and the
presence of multifocal or diffuse lesions, but postmortem examin-
ation confirmation is lacking in those cases. Overall, pitfalls of
this study are its retrospective character, the lack of histopatho-
logical confirmation and infectious disease testing in a number of
cases. In contrast, MUA is considered a clinical and imaging diag-
nosis in cases where definitive brain histology is lacking.
Conclusions
Twenty-five per cent of dogs diagnosed with MUA in this study
were considered large breed dogs. Ignoring this population of
dogs would underestimate the prevalence of MUA in the overall
canine population. Large breed dogs presented significantly more
often with a decreased mentation compared with small/medium
breed dogs. The MST was not significantly different between
small/medium and large breed dogs, 281 and 106 days, respect-
ively, leading to a guarded prognosis for all dogs diagnosed with
MUA and receiving immunosuppressive treatment. In conclu-
sion, MUA should be considered as a differential diagnosis in
dogs other than small or toy breeds that have signs suggestive of
inflammatory brain disease.
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